GeminIQ Website Logo

Viewing CORT free

Subscribe for full history, 90+ metrics, screener, watchlist...

CORCEPT THERAPEUTICS INC

CORT

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
11110912012510390128137129150136112
Marketable Securities Current
197229252297239233256243345261233243
Accounts Receivable Net Current
773960706562546054624135
Inventory Net
1313131212141288788
Loss Contingency Receivable Current
------00001414
Prepaid Expense And Other Assets Current
413641372440221926242820
Assets Current
440426485541443439472467561503459432
Inventory Noncurrent
1915111281488889
Operating Lease Right Of Use Asset
775555566000
Property Plant And Equipment Net
532223331000
Marketable Securities Noncurrent
23617716010317324822016719405760
Other Assets Noncurrent
355887777677
Deferred Income Tax Assets Net
179182168153162144131127112989187
Assets
889815837824802846841784715656622594
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
153340342428151919131717
Accrued Liabilities Current
11580911089189917959605270
Operating Lease Liability Current
221111100000
Liabilities Current
15414916617214514314112610197105122
Loss Contingency Accrual Carrying Value Current
------00001414
Operating Lease Liability Noncurrent
885566666-0-
Accrued Income Taxes Noncurrent
151515141614141312111010
Liabilities
183177189192166163161145118108115132
Stockholders Equity
Preferred Stock Value Outstanding
-0---00--00-
Preferred Stock Value
0-000-000--0
Common Stock Value
000000000000
Treasury Stock Common Value
-998-977-967-923-867-745-696-682-651-641-635-632
Additional Paid In Capital Common Stock
1,0491,002969934901863832806781758739722
Accumulated Other Comprehensive Income Loss Net Of…
012221-02001-0
Retained Earnings Accumulated Deficit
655612643619599564544513466430403371
Stockholders Equity
706638648632636683680639596548507462
Liabilities And Stockholders Equity
889815837824802846841784715656622594
Preferred Stock Par Or Stated Value Per Share
--0.001---0.001---0.001-
Preferred Stock Shares Authorized
--10---10---10-
Preferred Stock Shares Outstanding
--0---0---0-
Common Stock Par Or Stated Value Per Share
--0.001---0.001---0.001-
Common Stock Shares Authorized
--280---280---280-
Common Stock Shares Issued
--143---138---134-
Shares Outstanding
--106---105---103-
Treasury Stock Common Shares
--37---33---31-

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202629.45%71.78%94.58%---------
20254.90%-0.97%-7.64%4.70%19.87%17.15%11.67%16.24%-38.14%-5.04%26.54%54.52%
202415.24%25.80%41.88%-4.76%15.66%36.19%22.71%9.62%17.96%-7.43%-1.78%18.48%
2023---26.87%26.51%11.64%-9.83%16.63%-13.07%-3.35%3.03%0.25%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.86
2.86
2.92
3.14
3.06
3.07
3.35
3.70
5.57
5.18
4.39
3.54
Quick Ratio
2.50
2.53
2.60
2.85
2.81
2.69
3.11
3.49
5.23
4.86
4.05
3.31
Working Capital
285.87M
276.85M
319.38M
368.87M
298.45M
295.44M
330.83M
340.76M
460.10M
406.17M
354.13M
309.65M
Leverage & Debt
Debt to Equity
0.26
0.28
0.29
0.30
0.26
0.24
0.24
0.23
0.20
0.20
0.23
0.29
Debt Ratio
0.21
0.22
0.23
0.23
0.21
0.19
0.19
0.19
0.17
0.16
0.18
0.22
Efficiency & Turnover
Asset Turnover TTM
0.98
0.93
0.91
0.92
0.94
0.91
0.92
0.91
0.92
0.82
0.80
0.80
Days Sales Outstanding TTM
31.08
23.94
27.27
31.85
30.18
32.84
25.71
27.39
27.68
32.79
27.31
25.97
Receivables Turnover TTM
11.74
15.25
13.39
11.46
12.10
11.12
14.20
13.32
13.19
11.13
13.37
14.05
Per Share Metrics
Diluted EPS TTM
0.46
0.46
0.83
0.89
1.11
1.12
1.24
1.24
1.13
1.07
0.95
0.82
Free Cash Flow Per Share TTM
1.01
1.15
1.37
1.58
1.73
1.70
1.90
1.37
1.20
1.21
1.23
1.51
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
98.30%
98.25%
98.30%
98.19%
98.37%
98.43%
98.39%
98.44%
98.49%
98.54%
98.66%
98.65%
Operating Profit Margin TTM
0.77%
-1.07%
5.88%
8.85%
14.24%
16.17%
20.29%
22.81%
22.46%
23.29%
22.24%
21.80%
Net Profit Margin TTM
6.57%
6.19%
13.09%
14.35%
18.63%
19.51%
20.92%
22.48%
22.12%
22.54%
22.00%
20.31%
Growth Metrics
Net Revenue Growth (1Y)
16.02%
12.20%
12.79%
17.92%
25.71%
30.93%
39.94%
39.67%
33.04%
26.51%
20.04%
13.18%
Net Income Growth (1Y)
-59.07%
-64.40%
-29.43%
-24.71%
5.88%
13.31%
33.04%
54.59%
33.13%
24.89%
4.66%
-21.78%
EPS Growth (1Y)
-59.56%
-64.52%
-29.86%
-24.84%
4.87%
11.88%
33.46%
52.56%
31.64%
31.08%
7.92%
-17.87%
Valuation Metrics
P/E TTM
167.83
88.44
36.27
80.90
57.29
88.91
36.84
33.86
26.59
21.94
31.69
30.41
P/B TTM
12.98
6.60
5.58
13.62
12.02
17.40
7.65
7.49
5.62
4.73
6.64
6.02
P/S TTM
11.03
5.47
4.75
11.61
10.67
17.35
7.71
7.61
5.88
4.95
6.97
6.18
Market Cap
9.16B
4.21B
3.61B
8.61B
7.64B
11.89B
5.20B
4.78B
3.35B
2.59B
3.36B
2.78B
Enterprise Value
9.05B
4.10B
3.49B
8.48B
7.54B
11.80B
5.07B
4.65B
3.22B
2.44B
3.23B
2.67B
Calculated Values
Free Cash Flow TTM
106.92M
120.15M
141.79M
163.32M
180.50M
177.03M
196.12M
142.07M
123.29M
124.70M
126.90M
154.37M
Net Debt
-111.04M
-109.99M
-120.50M
-125.14M
-103.75M
-90.82M
-127.67M
-137.29M
-128.59M
-149.75M
-135.55M
-111.80M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-17Sale
Owner: Mahoney, David L
Title: -
Shares: 20,000
Price/Share: $84.53
Value: $1,690,600.00
Shares Owned: 26,147
Relationship: Director
Ownership: Indirect
2026-06-16Sale
Owner: Wilson, James N
Title: -
Shares: 10,000
Price/Share: $83.13
Value: $831,300.00
Shares Owned: 1,094,543
Relationship: Director
Ownership: Indirect
2026-06-15Sale
Owner: Mokari, Atabak
Title: Chief Financial Officer
Shares: 40,000
Price/Share: $81.31
Value: $3,252,400.00
Shares Owned: 16,130
Relationship: Officer
Ownership: Direct
2026-06-02Sale
Owner: Guyer, William
Title: Chief Development Officer
Shares: 20,000
Price/Share: $70.60
Value: $1,412,000.00
Shares Owned: 3,985
Relationship: Officer
Ownership: Direct
2026-06-01Sale
Owner: Mokari, Atabak
Title: Chief Financial Officer
Shares: 40,000
Price/Share: $70.00
Value: $2,800,000.00
Shares Owned: 15,257
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
67.09%
Inst. Shares: 70,060,272
Shares Outstanding: 104,435,000
2025-12-31
64.98%
Inst. Shares: 67,490,273
Shares Outstanding: 103,862,000
2025-09-30
65.69%
Inst. Shares: 68,014,568
Shares Outstanding: 103,545,000
2025-06-30
66.63%
Inst. Shares: 69,367,137
Shares Outstanding: 104,111,000
2025-03-31
70.23%
Inst. Shares: 73,109,598
Shares Outstanding: 104,106,000

CORCEPT THERAPEUTICS INC (CORT) — SEC Financial Statements & Analysis

CORCEPT THERAPEUTICS INC (CORT) is a pharmaceutical preparations company, incorporated in DE. CORCEPT THERAPEUTICS INC trades on Nasdaq as: CORT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CORCEPT THERAPEUTICS INC reported a 16.02% year-over-year revenue growth, a Gross Profit Margin of 98.30% (TTM), a Debt-to-Equity ratio of 0.26x, a Price-to-Sales (P/S) ratio of 11.03x (TTM), a Price-to-Book (P/B) ratio of 12.98x (TTM), at a market cap of $9.16B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
16.02%
Gross Profit Margin TTM
98.30%
Debt To Equity
0.26x
P/S TTM
11.03x
P/B TTM
12.98x
Market Cap
$9.16B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CORCEPT THERAPEUTICS INC in?

CORCEPT THERAPEUTICS INC (CORT) operates in the Pharmaceutical Preparations industry.

What is CORT's market cap?

CORCEPT THERAPEUTICS INC (CORT) has a market capitalization of $9.16B as of 2026-06-30.

What is CORT's P/E ratio?

CORCEPT THERAPEUTICS INC (CORT)'s trailing twelve month P/E ratio is 167.83x as of 2026-06-30.

What exchange does CORT trade on?

CORCEPT THERAPEUTICS INC (CORT) trades on the Nasdaq.

Where is CORCEPT THERAPEUTICS INC incorporated?

CORCEPT THERAPEUTICS INC is incorporated in DE.

Wall Street's data.
Main Street's price.